Consun Pharmaceutical Group Limited (1681.HK)

HKD 9.64

(4.1%)

EBITDA Summary of Consun Pharmaceutical Group Limited

  • Consun Pharmaceutical Group Limited's latest annual EBITDA in 2023 was 963.05 Million CNY , up 22.65% from previous year.
  • Consun Pharmaceutical Group Limited's latest quarterly EBITDA in 2024 Q2 was 453.5 Million CNY , down 0.0% from previous quarter.
  • Consun Pharmaceutical Group Limited reported an annual EBITDA of 785.88 Million CNY in 2022, up 7.85% from previous year.
  • Consun Pharmaceutical Group Limited reported an annual EBITDA of 728.71 Million CNY in 2021, up 17.76% from previous year.
  • Consun Pharmaceutical Group Limited reported a quarterly EBITDA of N/A for 2023 FY, up 22.65% from previous quarter.
  • Consun Pharmaceutical Group Limited reported a quarterly EBITDA of 501.95 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Consun Pharmaceutical Group Limited (2023 - 2012)

Historical Annual EBITDA of Consun Pharmaceutical Group Limited (2023 - 2012)

Year EBITDA EBITDA Growth
2023 963.05 Million CNY 22.65%
2022 785.88 Million CNY 7.85%
2021 728.71 Million CNY 17.76%
2020 618.78 Million CNY 9.26%
2019 566.35 Million CNY -21.74%
2018 723.7 Million CNY 21.13%
2017 597.46 Million CNY 36.56%
2016 437.52 Million CNY 40.0%
2015 312.51 Million CNY 24.66%
2014 250.69 Million CNY 14.92%
2013 218.14 Million CNY 13.18%
2012 192.74 Million CNY 0.0%

Peer EBITDA Comparison of Consun Pharmaceutical Group Limited

Name EBITDA EBITDA Difference
Pak Fah Yeow International Limited 150.4 Million HKD -540.33%
Grand Pharmaceutical Group Limited 2.96 Billion HKD 67.536%
Extrawell Pharmaceutical Holdings Limited -129.51 Million HKD 843.558%
Wai Yuen Tong Medicine Holdings Limited 113.79 Million HKD -746.286%
Qianhai Health Holdings Limited -50.22 Million HKD 2017.331%
Lee's Pharmaceutical Holdings Limited 109.82 Million HKD -776.94%
Essex Bio-Technology Limited 418.37 Million HKD -130.189%
Tongfang Kontafarma Holdings Limited 76.63 Million HKD -1156.712%
PuraPharm Corporation Limited -26.16 Million HKD 3780.141%
SSY Group Limited 2.11 Billion HKD 54.456%
JBM (Healthcare) Limited 204.39 Million HKD -371.185%
Jacobson Pharma Corporation Limited 429.92 Million HKD -124.008%
China Resources Pharmaceutical Group Limited 15.43 Billion HKD 93.759%